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Abstract
Background:  Serratia marcescens, a frequent agent of catheterization-associated bacteriuria,
strongly adheres to human bladder epithelial cells in culture. The epithelium normally provides a
barrier between lumal organisms and the interstitium; the tight adhesion of bacteria to the epithelial
cells can lead to internalization and subsequent lysis. However, internalisation was not shown yet
for S. marcescens strains.
Methods: Elektronmicroscopy and the common gentamycin protection assay was used to assess
intracellular bacteria. Via site directed mutagenesis, an hemolytic negative isogenic Serratia strain
was generated to point out the importance of hemolysin production.
Results: We identified an important bacterial factor mediating the internalization of S. marcescens,
and lysis of epithelial cells, as the secreted cytolysin ShlA. Microtubule filaments and actin filaments
were shown to be involved in internalization. However, cytolysis of eukaryotic cells by ShlA was
an interfering factor, and therefore hemolytic-negative mutants were used in subsequent
experiments. Isogenic hemolysin-negative mutant strains were still adhesive, but were no longer
cytotoxic, did not disrupt the cell culture monolayer, and were no longer internalized by HEp-2
and RT112 bladder epithelial cells under the conditions used for the wild-type strain. After wild-
type  S. marcescens became intracellular, the infected epithelial cells were lysed by extended
vacuolation induced by ShlA. In late stages of vacuolation, highly motile S. marcescens cells were
observed in the vacuoles. S. marcescens was also able to replicate in cultured HEp-2 cells, and
replication was not dependent on hemolysin production.
Conclusion:  The results reported here showed that the pore-forming toxin ShlA triggers
microtubule-dependent invasion and is the main factor inducing lysis of the epithelial cells to release
the bacteria, and therefore plays a major role in the development of S. marcescens infections.
Background
The opportunistic pathogen Serratia marcescens is a com-
mon cause of urinary tract and ocular lens infections. It
has also been linked with endocarditis, osteomyelitis, sep-
ticemia, wound and respiratory tract infections [12]. There
have been frequent reports of S. marcescens outbreaks in
intensive care and neonatal care units [3,8,11,29]. Poten-
tial virulence factors involved in this pathogenicity are
proteases, a nuclease, a lecitinase, and the hemolysin, all
of which are secreted by the bacterium. A 56-kDa serine
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protease from S. marcescens has been shown to promote
keratitis by cleaving IgG, IgA, and lysozyme [16]. The best-
studied pathogenicity factor is the hemolysin ShlA, which
causes hemolysis of human and animal erythrocytes [32]
and the release of the inflammatory mediators histamine
and leucotrienes from leukocytes [18]. A previous study
[24] has shown an increase in the pathogenicity of
Escherichia coli strain 536/21 after transformation with the
S. marcescens hemolysin genes. The renal colonization of
this strain was more than five times higher than that of the
ShlA-negative recipient strain in an experimental rat
pyelonephritis model. In addition, this hemolysin has
been shown to be cytotoxic to epithelial cells in culture
[15]. These data imply a major role of the hemolysin in
pathogenicity; however, the experiments have been
mostly carried out with the purified hemolysin protein.
Recently, it has been shown in a Caenorhabditis elegans
infection model that a ShlA-negative mutant is no longer
pathogenic [20]. Although there are frequent reports of
nosocomial  Serratia  outbreaks, the molecular mecha-
nisms of S. marcescens pathogenicity in vivo are still
poorly understood.
The first step in infection is adhesion to the target tissue
surface. S. marcescens has the ability to attach to hydro-
phobic surfaces. Tight adhesion to a variety of surfaces,
mainly by hydrophobic interaction, has been shown
[2,5,7,23]. Adhesion to epithelial cells mediated by the
type 1 fimbriae of S. marcescens has been described
[22,39], and the fimbriae of S. marcescens have been
shown to contribute to superoxide production [24,26]
and phagocytosis [26]. These findings underline the
importance of a tight physical contact of S. marcescens to
the target cell in pathogenicity.
Bacterial species capable of secreting a homologous
cytolysin are Proteus mirabilis, Edwardsiella tarda, and Hae-
mophilus ducreyi. P. mirabilis adheres to urinary tract tissues
by fimbriae. Invasion of P. mirabilis after adherence is
mainly determined by their „swarming motility" [1].
Edwardsiella tarda has also been shown to be intracellular
[17]. We are not aware of any report in the literature show-
ing any strain of S. marcescens with an invasive phenotype.
In a parallel study, we have shown that invasive S. marces-
cens cells adhere to the bladder carcinoma cell line RT112
and other epithelial cells mainly via type I fimbriae [14].
Here, we showed that S. marcescens strains with a reduced
adhesive phenotype were also reduced in their invasive-
ness. Invasion was not only influenced by the adhesion
capacity, but also by the expression of the cytolysin.
Hence, we discovered a new feature of the opportunistic
pathogen  S. marcescens – the invasiveness in various
human epithelial cell lines.
Methods
Bacterial strains, plasmids, growth conditions, and 
epithelial cell lines
The bacterial strains, plasmids, and epithelial cell lines
used in this study are listed in Table 1. Bacterial cells were
grown in TY medium consisting of 0.8% tryptone [Difco
Laboratories], 0.5% yeast extract, and 0.5% NaCl at pH
7.0.
Cell cultures
Cultures of HEp-2 cells [ATCC CCL 23] were maintained
in Dulbecco's minimal essential medium [DMEM] sup-
plemented with 5% fetal bovine serum without antibiot-
ics. RT112 cells [bladder carcinoma cell line] were
maintained in Waymouth's medium supplemented with
10% fetal bovine serum without antibiotics. HeLa [ATCC
CCL 2] and Hec1-B [ATCC HTB 113]] cells were main-
tained in RPMI medium supplemented with 10% fetal
bovine without antibiotics. Cells were grown in 75-cm2
flasks at 37°C under a 5% CO2, humidified atmosphere.
Confluent stock cultures were trypsinized and seeded in
96-well culture plates [Corning Costar, Wiesbaden, Ger-
many] and incubated until confluent.
Construction of plasmid pRSM03 carrying shlB/shlA 
internal sequences for site-directed mutagenesis
The kanamycin box from plasmid pUC4-K was excised
with SalI and ligated into SalI-digested plasmid pGP704,
yielding pRSM01 [5.0 kb, ApR, KmR], which was intro-
duced into Escherichia coli strain SM10[λpir] by transfor-
mation. The gene fragment encoding the C-terminal
domain of ShlB [from position 654 to 1670 in shlB], the
intergenic region including the promoter of shlA [from
position 1671 to 1718] and the N-terminal domain of
ShlA [from position 1719 to 2486] was generated by
excising a 1.832-kb SphI fragment from pRO2 and ligating
this fragment into the SphI site of pRSM01, yielding
pRSM02 [6.8 kb]. pRSM02 was digested with SgrAI and
religated to give pRSM03. This step looses a 741-bp inter-
nal DNA fragment, encoding the 22 C-terminal amino
acids [aa] from ShlB and 190 N-terminal aa from ShlA.
The resulting suicide plasmid was introduced into S. marc-
escens strain W225 by conjugation. Out of 800 kanamy-
cin-resistant exconjugants, two were shown to be
hemolytic negative. Homologous recombination was
confirmed by sequencing chromosomal PCR fragments
derived from the shlB/shlA locus.
For complementation of hemolytic negative S. marcescens
mutants, a polyvalent expression vector (pMMB67EH)
was used. The shlB/shlA operon from pRO3 was excised
with BamHI/HindIII and ligated into pMMB67EH yield-
ing pRSC01. pRSC01 was transformed into E. coli HB101
containing the helper plasmid pRK2013. This strain was
then conjugated with S. marcescens mutant strain SM001.BMC Infectious Diseases 2004, 4 http://www.biomedcentral.com/1471-2334/4/16
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Exconjugants were isolated under carbenicillin restriction
(100 µg/ml) and by eliminating HB101 with 5 µg/ml tet-
racycline, against which S. marcescens is resistant.
Hemolysis assay
Hemolysis was determined as described previously [6,15].
Briefly, serial dilutions of hemolytic samples were pre-
pared with phosphate-buffered saline [PBS] or HU buffer
[6 M urea in 50 mM HEPES [N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid], pH 6.8]; 100-µl aliquots of
each dilution were incubated with 1 ml of erythrocyte sus-
pension for 15 min at 22°C and then centrifuged for 1
min in a microcentrifuge. The absorbance at 405 nm
[A405] of released hemoglobin was measured
spectroscopically.
Adhesion assay
S. marcescens was cultivated for 18 h in TY medium with
shaking at 29°C. Bacteria were harvested by centrifuga-
tion and washed once with HBSS [Hank's balanced salt
solution, Sigma, St. Louis, Mo.]. Bacteria were resus-
pended in HBSS and adjusted to an optical density at 578
nm of approximately 0.5 [≈5 × 108 cells/ml]. A 100-µl
aliquot of a 1:10 dilution of bacteria in HBSS was centri-
fuged in a 96-well plate onto, with 3.7% paraformalde-
hyde [PFA] solution [0.2 N HEPES, pH 7.2; 3.7% PFA,
Sigma, St. Louis, Mo.] freshly fixed epithelial cells [1 × 105
cells/well]. This equals a multiplicity of infection [MOI] of
50 bacteria per cell. Bacterial suspensions were incubated
with the fixed, washed cells in HBSS for 1–2 h at 37°C.
Adherent bacteria were determined by MTT [3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl-tetrazoliumbromide]
as described [19]. For microscopy, adherent epithelial
cells were cultivated on a cover slip, fixed or left unfixed,
and then incubated with bacteria for 1–2 h at 37°C. After
washing, the bacteria were fixed with 70% ethanol and
stained with 10% Giemsa stain.
Table 1: Bacteria, plasmids, and epithelial cells used in this study
Strains/plasmids/cell lines relevant genotype source or reference
E. coli
BL21 [DE3] F-, hsdS gal, lysogenic for phage λ carrying the phage T7 RNA polymerase 
gene under lacUV5 control
[36]
SM10[λpir] thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::mu, Kmr, λpir [28]
HB101 ara leu pro lac gal rpsL supE44 xyl mtl recA hsd9 (hsdR hsdM) Stratagene
S. marcescens
W225 human isolate [31]
SM001 W225 shlB/shlA::kan, nonhemolytic this study
SM011 W225 shlB/shlA::kan, nonhemolytic this study
VA 15854 human isolate [31]
W1128 human isolate [30]
ATCC25419 human isolate [31]
CDC 04:H4 human isolate [31]
Other strains
Proteus mirabilis VI human isolate [34]
Pseudomonas aeruginosa PAO1 S. Lory
Plasmids
pGP704 Apr; ori R6 K, mob RP4, MCS of M13tg131 [13]
pRK2013 conjugative IncP helper plasmid ATCC 37159
pMMB67EH multi-host cloning and expression vector ATCC 37622
pRSC01 pMMB67EH shlB shlA this work
pUC4-K Apr, Kmr; MCS [37]
pRSM01 Apr, Kmr; ori R6 K, mob RP4, MCS of M13tg131 this work
pRSM02 pRSM01, 1.8-kb SphI fragment of pRO2 [shlB'/shlA'] this work
pRSM03 pRSM02, SgrAI deletion [shlB/shlA, ∆ bp 1544–2285] this work
pRO3 pT7-5 shlB shlA [28]
pRO2 pT7-5 shlB shlA, ∆ aa 256–1578 [28]
Epithelial cells
RT112 human bladder epithelial carcinoma cell line MPI Tübingen
HEp-2 human larynx epidermoid carcinoma cell line ATCC CCL23
HeLa human cervix epitheloid carcinoma cell line ATCC CCL 2
Hec1-B human endometrial adenocarcinoma cell line ATCC HTB 113BMC Infectious Diseases 2004, 4 http://www.biomedcentral.com/1471-2334/4/16
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Gentamycin protection assay
HEp-2 and RT112 epithelial cells were cultured in a 24-
well plate until they reached confluence. The number of
cells was determined. Bacterial cultures were grown to
mid-exponential phase and centrifuged. The bacterial
cells were resuspended in appropriate volumes of HBSS;
100 µl of the suspension was added to each well of a 24-
well plate containing nearly confluent monolayers of ~5 ×
104 epithelial cells per well and incubated for 2 h at 37°C.
The gentamycin protection assay was carried out as previ-
ously described [21]. The concentration of 100 µg gen-
tamycin/ml used in the cell culture medium was toxic for
Proteus mirabilis VI,  E. coli BL21, and all S. marcescens
strains tested. After incubation, cells were washed three
times with PBS and lysed with 1% Triton X-100; the result-
ing supernatants were serially diluted and the CFU on LB
agar plates were determined. The results for each experi-
ment are the average of an assay performed in triplicate
and independently repeated three times.
For assaying intracellular replication, HBSS containing
100 µg gentamycin/ml was replaced after 2 h with either
HBSS or HBSS containing 4 µg gentamycin/ml. After incu-
bation for 1–2 h in HBSS [with or without gentamycin]
under a 5% CO2 atmosphere at 37°C, the number of via-
ble bacteria in the supernatant and cell-associated bacteria
were counted as described above.
Transmission electron microscopy
RT112 cells were incubated with W225 at an MOI of
approximately 5 for 60 min and then fixed with 3% glu-
taraldehyde. Ultra-thin slices of infected epithelial cell
monolayers were transferred to carbon-pioloform-coated
copper grids [200-mesh], stained by floating for 1 min on
a solution of 1% [w/v] uranyl acetate in water, briefly
washed in water, and air-dried. The grids were observed
with a Philips CM10 transmission electron microscope at
an acceleration voltage of 60 kV.
Determination of cytotoxicity using the lactate 
dehydrogenase [LDH] release assay
Release of LDH from eukaryotic cells indicates permeabil-
ity of the membrane and cell death. The amount of LDH
release was determined with a micro-plate assay according
to the instructions of the manufacturer [Roche, Man-
nheim, Germany].
Incubation with inhibitors
Epithelial cells were incubated with inhibitors [see Table
3] for 1 h at 37°C under a 5% CO2 atmosphere prior to
adding bacteria. The culture supernatant was replaced by
HBSS. The epithelial cells were then incubated with bacte-
ria as described for the gentamycin protection assay.
Results
Construction and characterization of isogenic hemolytic-
negative mutants of S. marcescens W225
To obtain homologous chromosomal recombination
with a defective hemolysin gene, a strategy according to
Mekkalanos [25] was used. Briefly, a C-terminal portion
of ShlB and an N-terminal fragment of ShlA were cloned
into the suicide vector pGP704, yielding pRSM02. With
an additional SgrAI-digest, a deletion of 741 bp between
shlB and shlA was created which included a C-terminal
portion of ShlB [22 aa] and an N-terminal portion of ShlA
[190 aa]. This plasmid [pRSM03] was introduced into S.
marcescens  strain W225 by conjugation. Homologous
chromosomal recombinants were selected for by
kanamycin resistance. Hemolytic-negative insertion
mutants were screened for by the absence of zones of lysis
on blood agar plates and by lack of lysis in a liquid hemo-
lysis assay. After isolation of hemolytic-negative mutants
SM001 and SM011, the genomic recombination region in
the shlB/shlA locus was amplified by PCR and sequenced
to confirm the mutation. Mutants SM001 and SM011
were confirmed as having the same insertion in, and dele-
tion of the intergenic shlB/shlA region including the pro-
moter and the N-terminal 190 aa of ShlA. The isogenic
hemolytic-negative mutant strains of S. marcescens W225
[SM001] and [SM011] were non-toxic on cultured
Table 3: Effects of various inhibitors on S. marcescens W225 invasion of RT112 epithelial cells
Inhibitor concentration [%] invasion MOI 2 [%] cytotoxicity MOI 2 [%] invasion MOI 10 [%] cytotoxicity MOI 10
None - 100 16.0 ± 2.4 100 90.0 ± 1.8
Chloroquine 200 µg/ml 98.0 ± 4.1 19.0 ± 1.8 97.2 ± 3.7 100
Cycloheximide 10 µg/ml 100 15.3 ± 2.6 102 ± 4.4 100
Cytochalasin D 5 µg/ml 54.0 ± 2.3 21.3 ± 2.6 62.0 ± 3.1 100
Dansylcadaverine 500 µM 100 18.2 ± 1.8 100 92.3 ± 5.4
Wortmannin 25 µM 55.0 ± 2.8 48.0 ± 4.4 3.0 ± 0.5 100
Colchizine 0.2 µg/ml 23.0 ± 2.1 7.2 ± 1.3 58.4 ± 6.3 46.8 ± 5.3
Paclitaxel 1 µg/ml 21.5 ± 3.2 11.7 ± 6.3 44.4 ± 5.8 40 ± 2.2BMC Infectious Diseases 2004, 4 http://www.biomedcentral.com/1471-2334/4/16
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epithelial tissue cells [Fig. 1]. However, SM011 showed a
residual cytotoxic activity reproducibly higher than strain
SM001 [for unknown reasons] and was therefore no
longer examined in this study.
Strain SM001 was then complemented with pRSC01, car-
rying the shlB/shlA  operon on the expression plasmid
pMMB67EH. Efficient restoration of hemolytic/cytotoxic
activity is shown in Fig. 1.
Adhesion of S. marcescens to cultured epithelial cells
All Serratia strains tested adhered specifically to confluent
monolayers of RT112 and HEp-2 cells. However, above an
MOI of 10, viable epithelial cells were lysed rapidly within
the first 15 min of incubation by the produced hemolysin.
The  S. marcescens hemolysin [ShlA] secretion, together
with the tight contact to the epithelial cells, is a serious
interfering factor in studies of bacterial adhesion and
internalization. Therefore, bacterial adherence was quan-
tified only on fixed cells with an MOI of 50 [Fig. 2]. These
data confirmed the adhesion capacity of our clinical iso-
lates to epithelial cells, but showed strain-specific differ-
ences in the yield. An LDH cytotoxicity assay on viable
cells showed that less-adherent strains were slightly less
cytotoxic at an MOI of 5 [Fig. 1] except hemolytic negative
mutant SM001 and E. coli BL21 expressing ShlA.
The use of the hemolytic-negative mutant of strain W225
circumvented the cytotoxicity and enabled the role of
ShlA in adhesion to be studied. The hemolytic-negative
mutant was not altered in adhesion capacity compared to
the wild-type, which provided evidence that the hemo-
lysin was not involved in adhesion [Fig. 2] as E. coli BL21,
pRO3, which secreted activated ShlA into the supernatant
with a portion of ShlA remaining cell bound [28], showed
a virtually non-adhesive phenotype.
Internalization and protection against gentamycin
To quantify the internalization of S. marcescens into epi-
thelial cells, a standard gentamycin protection assay [21]
[A] Cytotoxicity [by LDH assay] of different S. marcescens strains on RT112 cultured [black bars] and Hep-2 [gray bars] epithe- lial cells after 1-h incubation at 37°C [MOI 5] Figure 1
[A] Cytotoxicity [by LDH assay] of different S. marcescens strains on RT112 cultured [black bars] and Hep-2 [gray bars] epithe-
lial cells after 1-h incubation at 37°C [MOI 5]. E. coli [E.C.] BL21 pT7-5 served as a negative control.
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with the clinical S. marcescens isolates VA15854, W1128,
W225 and CDC04:H4 was used. Non-invasive E. coli BL21
was used as a control. The gentamycin protection assay
was first done with bacteria on PFA-fixed epithelial cells
[MOI 2, 10, and 50]; all bacteria, adherent to epithelial
cells or not, were efficiently killed by the procedure [data
not shown]. Hence, the bacteria were not protected from
gentamycin by tight adhesion or biofilm formation
within the 2-h incubation time. Initial attempts to charac-
terize S. marcescens host-cell interaction and invasion were
confounded by vacuolation and subsequent lysis of the
cells induced by secreted and/or cell-bound ShlA [15]. The
cytotoxic effect was also confirmed by measuring the cel-
lular ATP level, which markedly decreased within 15 min
[data not shown], and an LDH release cytotoxicity assay,
which indicated significant cell lysis at an MOI of 10 [Fig.
3]. To avoid the cytotoxicity effects, RT112 and Hep2 epi-
thelial cells were inoculated with E. coli BL21 or the S.
marcescens strains W1128, W225, CDC04:H4, and SM001
at an MOI of approximately 2. After 30 min post-infection
at 37°C, the epithelial cells appeared to be intact, and no
extended vacuolation was observed by phase-contrast
microscopy. After 60 min post-infection, cells appeared
compromised, but virtually still intact. Evidence of mostly
intact cells was given by negative trypan blue and propid-
ium iodide staining [data not shown]. After 120 min post-
infection, extended vacuolation was seen even with an
MOI of 1 to 2, and cell lysis increased, as was also shown
by propidium iodide uptake into nuclei and the video
taken with these experimental settings http://www.mikro
bio.uni-tuebingen.de/ag_hertle/projects/. Beyond 60 min
incubation time, you see an increasing number of extra-
cellular bacteria. These bacteria could either be from extra-
cellular proliferation or from lysed cells which had
released their intracellular bacterial load. To minimize
bacterial growth, the medium maintaining the epithelial
cells contained no serum, glutamine, or glucose [HBSS].
The increase in total bacterial yield after 2 h incubation
with the epithelial cells and without gentamycin was
about 5 to 10% of that of the inoculum [counted by plat-
ing dilutions].
After 2 h of gentamycin treatment, cells were lysed, and
viable bacteria were recovered by plating serial dilutions
on agar plates. S. marcescens strain W225 was the most
invasive of the strains tested [Fig. 4]. There were no signif-
icant differences in the infection of HEp-2, Hec1-B, or
HeLa cells with strain W225 [data not shown]. Only
RT112 cells seemed to be slightly more susceptible to S.
marcescens invasion. Therefore, strain W225 was taken as
the model strain on RT112 cells.
Relative adhesion of different S. marcescens strains on fixed RT112 [black bars] and Hep-2 [gray bars] epithelial cells after 1-h  incubation at 37°C [MOI 50] detected by the MTT assay Figure 2
Relative adhesion of different S. marcescens strains on fixed RT112 [black bars] and Hep-2 [gray bars] epithelial cells after 1-h 
incubation at 37°C [MOI 50] detected by the MTT assay. E. coli [E.C.] BL21 served as a negative control.
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The observation of intracellular bacteria was verified by
electron microscopy of infected monolayers, showing
bacteria enclosed in small and large vacuoles [Fig. 6].
Clearly visible bacteria are marked by arrows. Other struc-
ture in the vacuoles could not be identified clearly but
may be bacteria outside the center of the cutting level.
Invasion is dependent on hemolysin production and 
adhesion
Owing to the cytotoxicity of strain W225, it was necessary
to use an MOI of 2 or below in order to minimize cytotox-
icity. The hemolytic-negative derivative of strain W225
defective in hemolysin production and cytotoxicity [strain
SM001], enabled bacterium–host interactions to be stud-
ied without killing the host cells too early. SM001 was
much lower in its invasive ability than the parental strain
[Fig. 4]. At a maximal MOI of 2, the mutant strain SM001
entered RT112 cells nearly ninety fold less efficiently than
the parental strain W225, even though it adhered at a sim-
ilar level [Table 2]. The complemented mutant strain
SM001 pRSC01 showed about 88% of the wildtype activ-
ity in invasion [Fig. 4]. To confirm hemolysin secretion,
the strains were cultured together with human erythro-
cytes. The lysis kinetics due to hemolysin secretion are
shown in Fig. 5. Recombinant hemolysin-producing E.
coli HB101 [pRSC01] [Fig. 4] or E. coli BL21 [pRO3] were
not enhanced in adhesion or in invasion [Table 2]. How-
ever, at a higher MOI [Table 2], different results were
obtained. With hemolytic-negative mutant strain SM001,
internalization was 3.3-fold higher at an MOI of 10 com-
pared to the wild-type strain W225. At an MOI of 10, the
wild-type strain lysed nearly all epithelial cells during
incubation [cytotoxicity in Table 2], which led to a
decrease in the amount of viable intracellular bacteria
protected against gentamycin. The complemented SM001
pRSC01 showed a slightly lower invasion rate but higher
cytotoxicity [Table 2], which may due to the higher level
of hemolysin expression with more copies of the expres-
sion vector, compared to the wild type W225.
Highly motile bacteria are found inside vacuoles
After 1 h post-infection with an MOI of 2 and following 1-
h gentamycin treatment, highly motile bacteria were
observed inside medium-sized [15–20 µm] vacuoles. The
Cytotoxicity [by LDH assay] of different S. marcescens strains at an MOI of 2 [gray bars] and an MOI of 10 [black bars] on  RT112 epithelial cells Figure 3
Cytotoxicity [by LDH assay] of different S. marcescens strains at an MOI of 2 [gray bars] and an MOI of 10 [black bars] on 
RT112 epithelial cells.
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swimming speed of the bacteria [20 ± 5 µm/s] was about
three- to fourfold higher inside the vacuoles than outside
the cell [see movie at http://www.mikrobio.uni-tuebin
gen.de/ag_hertle/projects/ or additional file "movie"].
The video shows high motile S. marcescens W225 inside
RT112 epithelial cell vacuoles. The video is divided in 10
sec scenes. Scene 1: 60 min after infection with MOI of 2
appears like the control except small pinpoint vacuoles;
Table 2: Invasion, adhesion and cytotoxicity of different bacterial strains at low and high MOI. Invasion: RT112 cells incubated for 2 h, 
37°C with bacteria prior to addition of 100 µg/ml gentamicin; adhesion was measured by the MTT assay as described; cytotoxicity was 
determined at MOI 2 and 10 after 2 h of incubation.
MOI 2 MOI 10
Invasion
S. marcescens W225 5669 ± 213 4234 ± 877
S. marcescens SM001 64 ± 23 13986 ± 1322
SM001 pRSC01 5011 ± 197 3698 ± 762
E. coli BL21 [pRO3] 2 ± 1.3 46 ± 12
Relative adhesion OD492 [%]
S. marcescens W225 not detected 0.60 ± 0.059 100 ± 9.9
S. marcescens SM001 not detected 0.59 ± 0.076 99.6 ± 12.8
SM001 pRSC01 not detected 0.58 ± 0.112 96.6 ± 18.8
E. coli BL21 [pRO3] not detected 0.0 ± 0.017 0 ± 2.8
Absolute cytotoxicity [%]
S. marcescens W225 16 ± 2.4 90 ± 1.8
S. marcescens SM001 0 7 ± 0.4
SM001 pRSC01 19 ± 3.2 95 ± 4.3
E. coli BL21 [pRO3] 0 22 ± 0.4
Invasion of different strains in cultured RT112 epithelial cells after 2-h incubation at 37°C at an MOI of 2 Figure 4
Invasion of different strains in cultured RT112 epithelial cells after 2-h incubation at 37°C at an MOI of 2.
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scene 2: 90 min after infection, visible vacuolation with
single extracellular bacteria; scene 3: 120 min after infec-
tion, extended vacuolation with attached and swimming
extracellular bacteria, addition of 100 µg/ml gentamycin;
scene 4: 60 min later, osmotic swollen RT112 cells with
intracellular bacteria. S. marcescens cells, driven by
flagellae, changing their swimming direction after hitting
the vacuolar membrane; scene 5–7: 90 min after gentamy-
cin addition (210 min after infection), S.-marcescens-con-
taining cells were detached from the tissue culture well,
and appeared round and short before being osmotically
lysed. In these compartments, up to six highly motile
bacterial cells were counted. However, most vacuoles con-
tained no bacteria.
Intracellular replication of S. marcescens
After 2 h of gentamycin treatment of infected epithelial
cells [MOI of approximately 1], the culture medium was
changed to HBSS with [4 µg/ml] or without gentamycin.
The CFU of the culture supernatant and of the intracellu-
lar bacteria were periodically monitored up to 2 h. Owing
to lysis of the epithelial cells maintained in HBSS contain-
ing gentamycin, the number of recoverable CFU of intrac-
ellular bacteria decreased. The CFU in the supernatant
remained almost zero. In contrast, in gentamycin-free
HBSS, the CFU in the supernatant increased continuously
[data not shown]. The increase of CFU isolated from the
adherent cultured cells from the initial 2,000 CFU to
5,500 CFU [Fig. 7] clearly showed that internalized S.
marcescens cells were able to replicate inside the epithelial
cells. The replication factors of intracellular S. marcescens
cells were estimated to be 2.5 to 2.9/h for W225 compared
to 2.5/h for the Pseudomonas aeruginosa PA01 control.
However, during the incubation, epithelial cells were
lysed by the bacteria, and higher numbers of CFU could
be counted in the supernatant without gentamycin [data
not shown]. Considering the CFU in the supernatant and
cell-bound CFU together, the replication factors were esti-
mated to be 3.4 ± 0.04/h for wild-type strain W225, 4.0 ±
0.11/h for mutant SM001 and only 2.6 ± 0.02/h for the
control P. aeruginosa PAO1. Internalized hemolytic nega-
tive-mutant strain SM001 showed only a slight increase of
the bacterial load in the supernatant compared to the iso-
genic wild-type strain. Despite the initial lower
Hemolysis of human erythrocytes in coculture with bacterial cells; (◆ )W225; ()SM001; (■ )SM001 pRSC01; (▲ )HB101  pRSC01; ()HB101 pMMB67EH; (❍ )BL21 pRO3; (x)BL21 pT7-5 Figure 5
Hemolysis of human erythrocytes in coculture with bacterial cells; (◆ )W225; ()SM001; (■ )SM001 pRSC01; (▲ )HB101 
pRSC01; ()HB101 pMMB67EH; (❍ )BL21 pRO3; (x)BL21 pT7-5.
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internalization level of mutant strain SM001, the propor-
tion of internalized bacteria had a similar doubling time
as the wild type W225. However, the number of CFU of
mutant SM001 cells in the epithelial cells provided evi-
dence that the hemolysin ShlA was not necessary for
intracellular replication, but might play a role in the
release from the cells.
Inhibitors of epithelial cell invasion
To determine the effects of various inhibitors on S. marc-
escens invasion, monolayers of RT112 epithelial cells were
preincubated with each of the agents for 1 h. At an MOI of
2 and 10, inhibitors of protein biosynthesis [cyclohex-
imide], receptor recycling [chloroquine] and receptor-
mediated endocytosis [monodansylcadaverine] had no
effect on RT112 invasion [Table 3]. At MOI 2, wortman-
nin increased the cytotoxicity of S. marcescens W225, and
in turn decreased invasion. At MOI 10, virtually no epithe-
lial cell remained intact to protect bacteria from gentamy-
cin. As shown in Table 3, at MOI 2, cytochalasin D
[depolymerizes actin filaments] decreased and colchizine
[depolymerizes microtubules] and paclitaxel [stabilize
"freeze" microtubules] inhibited invasion of S. marcescens
strain W225 in RT112 epithelial cells. At a higher MOI [10
CFU/cell] colchizine and paclitaxel each decreased the
yield of intracellular bacteria compared with epithelial
cells not pretreated with one of these inhibitors. Simulta-
neously, cytotoxicity was tempered in increase at an MOI
10 [Table 3, right columns]. In contrast, cytochalasin D
and wortmannin [vesicle trafficking inhibitor] treatment
increased the cytotoxicity significantly even at an MOI of
2 and led to a decrease in viable epithelial cells, which led
to a decrease in the number of gentamycin-protected bac-
teria. Apparently, RT112 epithelial cells were stabilized
against the cytotoxic bacteria by inhibitors of microtubule
filaments, and more RT112 epithelial cells were still viable
despite the bacterial load. Therefore, protecting more
intracellular bacteria against gentamycin.
Discussion
S. marcescens as a pathogen shows a tissue-damaging
capacity [18,24]. The cytotoxic activity is mainly elicited
by the secreted hemolysin/cytotoxin ShlA [15]. However,
the role of ShlA, secreted directly by the bacteria during
infection remained elusive. Another pathogen, Edwards-
iella tarda, which has a hemolysin homologous to ShlA,
has been studied in more detail [35], and a direct correla-
tion between the presence of hemolysin and invasion in
epithelial cells has been shown. Here, S. marcescens strains
were tested for internalization in RT112 bladder epithelial
cells and in HEp-2 cells using a commonly used gentamy-
cin protection assay. S. marcescens was found to be
Transmission electron micrographs of adherent S. marcescens W225 cells on RT112 epithelial cells and bacteria encapsulated in  small and large vacuoles Figure 6
Transmission electron micrographs of adherent S. marcescens W225 cells on RT112 epithelial cells and bacteria encapsulated in 
small and large vacuoles. Cells were incubated 60 min with W225 at an MOI of approx. 5. After significant vacuolisation was 
visible, cells were fixed with glutaraldehyde. Bacteria are marked by arrows. Bars represent 1 µm.
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intracellular. To our knowledge, this is the first report doc-
umenting S. marcescens as an invasive species. The number
of intracellular bacteria was dependent on the particular
bacterial strains, which differed in adhesion efficiency,
hemolysin production, and the target epithelial cell line.
The results showed that two main factors influence inva-
sion: adhesion and cytotoxicity.
One etiological mechanism in a urinary tract infection
involves efficient adhesion to the epithelial tissue. To
determine whether this mechanism is involved in the S.
marcescens tissue-cell-culture infection model, the adhe-
sion properties of several clinical isolates of S. marcescens
were first evaluated.
Adhesion and cytotoxicity properties of S. marcescens and
closely related organisms are described to some extent in
the literature. For Proteus mirabilis, fimbriae and properties
such as swarming are more important than hemolysin
production for host cell invasion [1]. Adhesion to epithe-
lial cells mediated by type 1 fimbriae of S. marcescens has
also been reported [22,39]. Fimbriae of S. marcescens also
contribute to superoxide production [24,26] and
phagocytosis [26]. Since S. marcescens W225 adhesion to
RT112 epithelial cells is mediated by type I fimbriae [14],
it is notable that type I fimbriae can function also as
invasins [4]. A role of the hemolysin in the adhesion proc-
ess has not been examined in detail. The secretion of
hemolysin interferes in adhesion studies with viable epi-
thelial cells by lysing the cultured cell monolayer. To
avoid cell lysis, adhesion has been studied best with fixed
epithelial cells. However, the hemolysin is generally cell
bound in S. marcescens [33]; therefore, ShlA might con-
tribute to adhesion of the bacteria. To unravel the poten-
tial adhesive role of ShlA, hemolytic-negative isogenic
chromosomal mutants of S. marcescens strain W225 were
created by site-specific mutagenesis. One selected hemo-
lytic-negative mutant, SM001, which lacks the shlB/A
intergenic region was not altered in adhesion. This S.
marcescens  W225 mutant was significantly reduced in
invasion at an MOI of 1 to 2 and was no longer cytotoxic.
Compelemtation with the wildtype hemolysin genes
Replication of S. marcescens strain W225, hemolytic-negative isogenic mutant of strain W225 [SM001], E. coli K12-5K [negative  control], and P. aeruginosa [positive control] inside RT112 epithelial cells after 60 min [black bars] Figure 7
Replication of S. marcescens strain W225, hemolytic-negative isogenic mutant of strain W225 [SM001], E. coli K12-5K [negative 
control], and P. aeruginosa [positive control] inside RT112 epithelial cells after 60 min [black bars]. Grey bars show the starting 
values of a MOI of 1 after 2 h treatment with 100 µg/ml gentamycin. Incubation was continued with 4 µg/ml gentamycin for 60 
min [black bars].
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rather restored the wildtype phenotype. Mutants of E.
tarda defective in secretion of the ShlA homologue cyto-
toxin EhlA showed a similar phenotype, being no longer
cytotoxic or invasive [35]. E. coli BL21 transformed with
the shlB/shlA genes showed only a small increase in adhe-
sion. That means that the hemolysin system is unlikely to
act as an adhesion factor. Increasing the bacterial load
increases the cytotoxicity, but in turn decreases the count-
able values of internalized and gentamycin protected bac-
teria due to lysis. This observation shows evidence for the
confounding role of the cytolysin in the measurement of
invasion in lytic doses.
It was clearly shown here that secretion of ShlA was the
main factor responsible for invasion at physiological low
infection doses. The related organism Haemophilus ducreyi
expresses a cell-associated hemolysin similar to ShlA.
Clinical isolates of H. ducreyi are invasive for human epi-
thelial cells, and the hemolysin enhances the invasion of
HEp-2 cells [38]. As in S. marcescens, cytotoxicity interferes
in adhesion and invasion assays on viable cells in culture.
Hence, ShlA facilitates the internalization and exploita-
tion of the host cell, but other factors may also play a role.
These results lead us to hypothesize that [i] a combination
of adhesion and cytotoxicity is essential for invasion, and
[ii] the invasiveness is a multi-factorial process in which
ShlA plays a major, but also confounding role. Tight adhe-
sion increased the cytotoxicity of the bacterial strains,
probably by bringing the cell-bound cytotoxin in close
contact to the target membrane. Subsequent perforation
of the cell membrane and mediation of host-cell invasion
by compromising and subsequent lysing the cells might
enable S. marcescens to penetrate tissue layers and invade
or disseminate in the host organism. This hypothesis is
supported by the data of the hemolysin producing E. coli
strains BL21, pRO3 and HB101 pRSC01. Virtually non-
adherent, they showed cytotoxicity [due to expression of
ShlA] but no internalization. In addition, the well adher-
ent but hemolytic negative mutant SM001 also showed
rather no internalization at an MOI of 2.
Once attached to the epithelial cell, the bacteria were
internalized. The cellular requirements of S. marcescens
internalization in cultured epithelial cells were evaluated
by pretreating the cells prior to Serratia application with a
variety of inhibitors that act on different eukaryotic
cellular processes and structures. Invasion of S. marcescens
W225 in RT112 cells or HEp-2 cells was not inhibited by
chloroquine and monodansylcadaverine, compounds
known to inhibit receptor recycling, receptor-mediated
endocytosis, and vesicle trafficking and therefore bacterial
entry [10]. However, the inhibitory result with
wortmannin have to be judged concerning the cytotoxic-
ity increasing capacity of this drug. This led to a decrease
of viable tissue cells and therefore to appearent lower
CFUs which were not correlated to a decrease in invasion
and incorrectly implicated an inhibition of invasion com-
pared to the untreated control. In this case, it is not possi-
ble to get a clear answer and the effect of wortmannin has
not have to be elucidated further.
Invasion of S. marcescens appeared to be dependent on
microfilaments, such as actin fibers and microtubules.
Disrupting actin filaments with cytochalasin D led to a
46% reduction in intracellular CFU, and colchizine treat-
ment reduced the intracellular CFU to 23–25% of that of
the controls. Therefore, only the CFU counted in the
background of low cytotoxicity is considered to be valid.
Our data showed that the inhibition of tubulin microfila-
ments by colchizine and paclitaxel resulted in both
reduced cytotoxicity and reduced invasion. We considered
this to be the only true case where invasion was inhibited
because the epithelial cells were still viable at the end of
the assay. Paclitaxel [taxol] "freezes" the microtubule net-
work by crosslinking tubulin whereas colchizine
depolimerizes tubulin fibers. The inhibition by both col-
chizine and paclitaxel implied a direct microtubule-driven
invagination of membrane-bound bacteria rather than an
uptake system involving microtubule filaments and a
molecular motor, e.g., dynein or a member of the kinesin
family. The movement of the activated motor system
along the microtubule linked to a membrane-receptor/
bacterium complex could cause invagination of the mem-
brane and internalization of the attached bacterium [27].
Such a system would be inhibited by colchizine, but not
by paclitaxel, and was therefore excluded by the results
obtained. The inhibitory effect caused by the dissolving of
actin microfilaments by cytochalasin D was masked by
the increased cytotoxicity and remains to be elucidated
further.
In contrast to other bacteria that replicate in the cyto-
plasm, such as Shigella flexneri or Listeria monocytogenes
[9], S. marcescens apparently has no direct effect on actin
and does not engage in direct cell-to-cell spreading
[unpublished observation]. Furthermore, an infected cell
adjacent to uninfected cells was typically observed.
It was clearly shown, that S. marcescens W225 and the
mutant SM001 replicated intracellularly. However, the
value of intracellular replication was changed by the cyto-
toxicity of S. marcescens W225. Because of the lysis of the
host cells, the number of gentamycin-protected bacteria
decreased with time, and more CFU were isolated from
the supernatant. The number of intracellular bacteria
might even be higher than counted because gentamycin is
lethal to bacteria in damaged and disintegrating cells
[depending on the time needed for gentamycin to access
the bacteria]. This was taken into account by changing theBMC Infectious Diseases 2004, 4 http://www.biomedcentral.com/1471-2334/4/16
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concentration of gentamycin from 100 µg/ml to 4 µg/ml
or 0 µg/ml. Bacteria, actually released from the epithelial
cells, can survive in the supernatant without gentamycin
and will form CFU on TY-agar plates. Since virtually all
extra cellular bacteria were killed by the gentamycin pre-
treatment, the sum of CFU recovered from the superna-
tant [without or low gentamycin] and the epithelial cells
reflects the true increase in bacterial yield. For this reason,
the CFU counts in gentamycin-protection assays have to
be judged carefully.
Conclusions
To summarize the data on the pathological phenotype of
S. marcescens on tissue culture cells, cytotoxicity is the
major factor. This cytotoxicity is excerted by a close con-
tact of the pathogenic bacteria to the host cell mediated by
fimbrial adhesion. The internalization observed at physi-
ologically low bacterial doses was shown to be dependent
on ShlA and on dynamic tubulin microfilaments. The
cytotoxin ShlA may facilitate the entry but it is not abso-
lutely necessary for internalization as shown by the
hemolytic-negative mutant strain. However, one could
suggest that cytotoxin production might kill immune cells
during inflammation and help the bacterium to escape
phagocytosis. This is an interesting hypothesis which
future examination will shed more light on the role of this
pore forming toxin in the pathogenicity of S. marcescens.
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